More than 350 firms reported lobbying on the 340B program between Oct. 1 and Dec. 31, 2024.
Federal 340B Lobbying Activity Held Steady in Q4 of 2024, Filings Show
The 340B drug discount program continued to be a hot topic for lobbyists in the final quarter of 2024, keeping [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.